GlycoMimetics News

Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50

MT NewswiresMay 7 07:10 ET

GlycoMimetics' Uproleselan: Hold Rating Amidst Strategic Reevaluation and Uncertain Future

TipRanksMay 6 15:05 ET

GlycoMimetics Analyst Ratings

BenzingaMay 6 13:59 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: GlycoMimetics (GLYC) and Gossamer Bio (GOSS)

TipRanksMay 6 12:10 ET

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), GlycoMimetics (GLYC)

TipRanksMar 28 08:20 ET

Positive Outlook for GlycoMimetics: Buy Rating Affirmed Amid Anticipated Pivotal Trial Results and Strategic Growth Initiatives

TipRanksMar 27 21:25 ET

GlycoMimetics Analyst Ratings

BenzingaMar 27 13:41 ET

Buy Rating on GlycoMimetics Backed by Strong Financials and Promising Phase 3 Trial of Uproleselan

TipRanksMar 27 11:35 ET

Promising Outlook for GlycoMimetics' Uproleselan in AML Treatment: A Buy Rating With Adjusted Price Target

TipRanksFeb 22 07:46 ET

Buy Rating Affirmed for GlycoMimetics Amidst Phase 3 Progress and Breakthrough Therapy Designation for Uproleselan

TipRanksJan 3 09:26 ET

Capital One Initiates Coverage On GlycoMimetics With Overweight Rating, Announces Price Target of $12

BenzingaDec 22, 2023 07:09 ET

GlycoMimetics Analyst Ratings

BenzingaDec 22, 2023 07:08 ET

Analysts' Top Healthcare Picks: GlycoMimetics (GLYC), Alignment Healthcare (ALHC)

TipRanksNov 3, 2023 10:20 ET

H.C. Wainwright Sticks to Their Buy Rating for GlycoMimetics (GLYC)

TipRanksSep 6, 2023 09:45 ET

GlycoMimetics Analyst Ratings

BenzingaAug 3, 2023 06:15 ET

HC Wainwright & Co. Reiterates Buy on GlycoMimetics, Maintains $8 Price Target

BenzingaJun 15, 2023 12:14 ET

H.C. Wainwright Keeps Their Buy Rating on GlycoMimetics (GLYC)

TipRanksJun 15, 2023 12:05 ET

HC Wainwright & Co. Reiterates Buy on GlycoMimetics, Maintains $8 Price Target

BenzingaMay 4, 2023 06:51 ET

H.C. Wainwright Keeps Their Buy Rating on GlycoMimetics (GLYC)

TipRanksMay 4, 2023 06:26 ET

GlycoMimetics (GLYC) Receives a Buy From H.C. Wainwright

TipRanksMar 30, 2023 06:16 ET